Cargando…

Proximal tubular dysfunction in patients with COVID-19: what have we learnt so far?

Recent studies have reported a variety of urine abnormalities in patients hospitalized due to severe acute respiratory syndrome coronavirus 2 infection. In a single-center study from Belgium, Werion et al. present a concise investigation of tubular dysfunction in patients with coronavirus disease 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braun, Fabian, Huber, Tobias B., Puelles, Victor G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480737/ https://www.ncbi.nlm.nih.gov/pubmed/32916178 http://dx.doi.org/10.1016/j.kint.2020.09.002

Ejemplares similares

Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022)

What have we learnt so far from COVID-19?
por: Doherty, Peter C.
Publicado: (2021)

COVID-19 and the heart: what we have learnt so far
por: Shaha, Kunal Bikram, et al.
Publicado: (2020)

Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Implementation of the Nagoya Protocol in Livestock Sector: What Have We Learnt So Far?
por: Martyniuk, Elzbieta, et al.
Publicado: (2021)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Alcohol consumption during COVID-19 pandemic: What have we learnt so far?
por: Nogueira, V., et al.
Publicado: (2021)

Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far?
por: Handy, Richard D., et al.
Publicado: (2012)

What we have learnt (so far) about deliberative dialogue for evidence-based policymaking in West Africa
por: Ridde, Valéry, et al.
Publicado: (2017)

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
por: Lazarevic, Ivana, et al.
Publicado: (2021)

COVID‐19 infection in CVID patients: What we know so far
por: Weifenbach, Niels, et al.
Publicado: (2021)

COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020)

Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2005)

Parliaments lead the change for women’s, children’s and adolescents’ health: what have we learnt?
por: Toure, Kadidiatou, et al.
Publicado: (2021)

The impact of economic crises on social inequalities in health: what do we know so far?
por: Bacigalupe, Amaia, et al.
Publicado: (2014)

Coagulation profile in severe COVID-19 patients: what do we know so far?
por: Savioli, Felicio, et al.
Publicado: (2020)

The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

OMICs in Cariology and Endodontology – what have we learned so far?
por: Zaura, Egija
Publicado: (2017)

Circadian Clocks in Fish—What Have We Learned so far?
por: Frøland Steindal, Inga A., et al.
Publicado: (2019)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
por: Barcellini, Amelia, et al.
Publicado: (2022)

ECMO Retrieval Program: What Have We Learned So Far
por: Krasivskyi, Ihor, et al.
Publicado: (2023)

Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?
por: Corsetti, Maura, et al.
Publicado: (2019)

What we know so far
Publicado: (2021)

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far
por: Jäckel, Claudia, et al.
Publicado: (2019)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)

Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far
por: Sawaya, Fadi, et al.
Publicado: (2019)

How Does SARS-CoV-2 Affect Our Eyes—What Have We Learnt So Far about the Ophthalmic Manifestations of COVID-19?
por: Baj, Jacek, et al.
Publicado: (2022)

Swine flu-have we learnt any lesson from the past?
por: Yadav, Sankalp, et al.
Publicado: (2015)

Defining transposition: What have we learnt?
por: Roderick, Max E., et al.
Publicado: (2021)

What have we learnt from Covid?
por: Salter, Mark Steven
Publicado: (2021)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Neural synchrony within the motor system: what have we learned so far?
por: van Wijk, Bernadette C. M., et al.
Publicado: (2012)

NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
por: Raut, Nirmal V, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lota19rlkca4u22g7q596g6a82